All News

Question from Russell: Male Osteoporosis I am 74 years old and had a CATscan 3 weeks ago. The xray doctor said that I had a 70% loss is my spine. My medical Doctor put me on Evista, I have been taking extra calcium along with the Evista. I had been taking Lipitor for high cholesterol but the Dr. took me off of that because my blood platelets had gone down to 121,000. Do you have any suggestions?

Sometimes even the simplest cases take on a life of their own. When a patient suffers a postoperative complication, but she's had two surgeries by two specialists in a short period of time, the disagreement between those specialists as to how the complication occurred, and in which surgery it occurred, can turn a straightforward "risk of the procedure" case into a medical mystery.

We know that tocolytic agents effectively inhibit uterine contractions, but the evidence for improved perinatal outcomes is much less clear. Why is this so, and what are the implications for your patients?

In the May 2006 issue of Obstetrics & Gynecology, the American College of Obstetricians and Gynecologists (ACOG) reaffirmed its recommendation that teenage girls first visit an OB/GYN between the ages of 13 and 15.

Questions this month have been answered by:Simon Kipersztok, MD, OBGYN.net Osteoporosis Editorial AdvisorHarvey S. Marchbein, MD, USA, OBGYN.net Osteoporosis Chairman and Editorial Advisor

The cost of malpractice premiums threatens our specialty's very survival. Yet powerful interest groups impede tort reform. What if, however, physicians concede the point that tort reform is not our priority? A strategy of if we can't beat them, join them might ultimately prove the key to the enduring solutions that we seek.

May Case Summaries

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

After reading the latest report from the Women's Health Initiative (WHI), I've struggled with my emotional reaction. The data in this report is not new. The risk of CHD was present only in the oldest women in the trials. . .

New Products

The latest in medical products for obstetrics and gynecology.

from The North American Menopause Society: The position statement evaluates the risk-benefit ratio of peri- and postmenopausal estrogen therapy and estrogen-progestogen therapy for both treatment of menopause-related symptoms and disease prevention.

New Products

The latest in medical products for obstetrics and gynecology

Array-based comparative genomic hybridization detects significantly more and smaller abnormalities than standard chromosome analysis. Already in limited use, the test may well replace karyotyping for prenatal diagnosis of genetic disorders.